[go: up one dir, main page]

AU6186499A - Agents for the immunotherapy of tumoral diseases - Google Patents

Agents for the immunotherapy of tumoral diseases

Info

Publication number
AU6186499A
AU6186499A AU61864/99A AU6186499A AU6186499A AU 6186499 A AU6186499 A AU 6186499A AU 61864/99 A AU61864/99 A AU 61864/99A AU 6186499 A AU6186499 A AU 6186499A AU 6186499 A AU6186499 A AU 6186499A
Authority
AU
Australia
Prior art keywords
immunotherapy
agents
tumoral diseases
tumoral
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU61864/99A
Inventor
Aida Kerkmann-Tucek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TUCEK AIDA KERKMANN
Original Assignee
TUCEK AIDA KERKMANN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TUCEK AIDA KERKMANN filed Critical TUCEK AIDA KERKMANN
Publication of AU6186499A publication Critical patent/AU6186499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/001136—Cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU61864/99A 1998-07-21 1999-07-21 Agents for the immunotherapy of tumoral diseases Abandoned AU6186499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19832840 1998-07-21
DE19832840A DE19832840C1 (en) 1998-07-21 1998-07-21 Means for immunotherapy of tumor diseases
PCT/DE1999/002280 WO2000004918A2 (en) 1998-07-21 1999-07-21 Agents for the immunotherapy of tumoral diseases

Publications (1)

Publication Number Publication Date
AU6186499A true AU6186499A (en) 2000-02-14

Family

ID=7874839

Family Applications (1)

Application Number Title Priority Date Filing Date
AU61864/99A Abandoned AU6186499A (en) 1998-07-21 1999-07-21 Agents for the immunotherapy of tumoral diseases

Country Status (4)

Country Link
EP (1) EP1098960A2 (en)
AU (1) AU6186499A (en)
DE (1) DE19832840C1 (en)
WO (1) WO2000004918A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60144515D1 (en) 2000-04-01 2011-06-09 Onyvax Ltd PROSTATE CELL LINES AND THEIR USE
AUPQ755300A0 (en) 2000-05-17 2000-06-08 Monash University Immune potentiating compositions
AU785241B2 (en) * 2000-05-17 2006-11-23 Cancure Limited Immune potentiating compositions
US20050019336A1 (en) 2003-07-23 2005-01-27 Dalgleish Angus George Human prostate cell lines in cancer treatment
CN1921882A (en) 2003-12-30 2007-02-28 莫洛根股份公司 Allogeneic tumor therapeutic agent
US20070065860A1 (en) * 2005-09-20 2007-03-22 Hildebrand William H Accelerated class I and class II HLA DNA sequence-based typing
JP2025507939A (en) * 2022-03-03 2025-03-21 ブリアセル セラピューティクス コーポレイション Cancer vaccines and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0569678A3 (en) * 1992-03-13 1994-10-26 Yeda Res & Dev Double transfectants of MHC genes as cellular vaccines for immunoprevention of tumor metastasis.
US5858776A (en) * 1993-11-03 1999-01-12 Repligen Corporation Tumor cells with increased immunogenicity and uses therefor
EP0869803B1 (en) * 1995-12-28 2003-04-16 The Johns Hopkins University School Of Medicine Allogeneic paracrine cytokine tumor vaccines

Also Published As

Publication number Publication date
EP1098960A2 (en) 2001-05-16
DE19832840C1 (en) 2000-06-08
WO2000004918A2 (en) 2000-02-03
WO2000004918A3 (en) 2000-04-20

Similar Documents

Publication Publication Date Title
AU698509B2 (en) Compositions for the treatment of rheumatoid-based arthritic diseases
AU2002219229A1 (en) Means for the diagnosis and therapy of CTCL
AU7902400A (en) Method for the preparation of 5-carboxyphthalide
HUP0201038A2 (en) Preparations for the application of anti-inflammatory agents
AU5762099A (en) The preparation of (n)-substituted-hydroxycycloalkylamine derivatives
AU5729099A (en) Use of cyclopentabenzofuran-derivatives for combating nf-KappaB-dependent diseases
AU6186499A (en) Agents for the immunotherapy of tumoral diseases
AU1434301A (en) Process for the preparation of sulfamides
AU5536599A (en) Process for the preparation of neotame
AU2376001A (en) Method for the manufacture of olefins
AU2021601A (en) Composition for the treatment of dandruff
AU3004000A (en) Methods for the treatment of apolipoprotein e related diseases
AU7095398A (en) Procedure for casting of building element; the lt-method
AU2829700A (en) Processes for the preparation of alpha-aminoketones
AU7752698A (en) Method for the synthesis of anti-microbial hydroxybenzoats
AU2002329441A1 (en) Process for the preparation of 3 - isochromanone
AU1130901A (en) Method for the preparation of 5-carboxyphthalide
AU5415900A (en) Process for the preparation of butoxycarbonylimino compounds and intermediates therefor
AU5779998A (en) Process for the preparation of cyanoarylmethylamine
AU6124499A (en) Process for the preparation of retinol and intermediates therefor
AU6281199A (en) Process for the preparation of cyclopropylacetylene
AU1798100A (en) Use of peptide
AU2002324291A1 (en) Process for the preparation of beta-ionylideneacetaldehyde
AU2001284736A1 (en) Haplotypes of the pla2g1b gene
AU1821900A (en) Process for the preparation of quinazolinones

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase